Menu
GeneBe

chrX-77968990-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001029891.3(PGAM4):​c.649G>A​(p.Val217Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,209,686 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000047 ( 0 hom. 9 hem. )

Consequence

PGAM4
NM_001029891.3 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 1.73
Variant links:
Genes affected
PGAM4 (HGNC:21731): (phosphoglycerate mutase family member 4) This intronless gene appears to have arisen from a retrotransposition event, yet it is thought to be an expressed, protein-coding gene. The encoded protein is a member of the phosphoglycerate mutase family, a set of enzymes that catalyze the transfer of a phosphate group from 3-phosphoglycerate to 2-phosphoglycerate. [provided by RefSeq, May 2010]
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03484398).
BP6
Variant X-77968990-C-T is Benign according to our data. Variant chrX-77968990-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 235208.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}. Variant chrX-77968990-C-T is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAdExome4 at 9 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PGAM4NM_001029891.3 linkuse as main transcriptc.649G>A p.Val217Ile missense_variant 1/1 ENST00000458128.3
ATP7ANM_000052.7 linkuse as main transcriptc.-21-2631C>T intron_variant ENST00000341514.11
ATP7ANM_001282224.2 linkuse as main transcriptc.-21-2631C>T intron_variant
ATP7ANR_104109.2 linkuse as main transcriptn.144-2631C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PGAM4ENST00000458128.3 linkuse as main transcriptc.649G>A p.Val217Ile missense_variant 1/1 NM_001029891.3 P1
ATP7AENST00000341514.11 linkuse as main transcriptc.-21-2631C>T intron_variant 1 NM_000052.7 P1Q04656-1

Frequencies

GnomAD3 genomes
AF:
0.0000445
AC:
5
AN:
112249
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34401
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000941
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00113
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000927
AC:
17
AN:
183319
Hom.:
0
AF XY:
0.0000442
AC XY:
3
AN XY:
67811
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000794
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000442
GnomAD4 exome
AF:
0.0000474
AC:
52
AN:
1097382
Hom.:
0
Cov.:
32
AF XY:
0.0000248
AC XY:
9
AN XY:
363226
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000852
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000463
Gnomad4 SAS exome
AF:
0.0000185
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000739
GnomAD4 genome
AF:
0.0000445
AC:
5
AN:
112304
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34466
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000939
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00113
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000869
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 27, 2022The c.649G>A (p.V217I) alteration is located in exon 1 (coding exon 1) of the PGAM4 gene. This alteration results from a G to A substitution at nucleotide position 649, causing the valine (V) at amino acid position 217 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsDec 05, 2014- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
11
DANN
Benign
0.94
DEOGEN2
Benign
0.090
T
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.72
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.035
T
MetaSVM
Benign
-0.67
T
MutationAssessor
Uncertain
2.8
M
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.72
N
REVEL
Benign
0.18
Sift
Uncertain
0.026
D
Sift4G
Benign
0.087
T
Polyphen
0.0020
B
Vest4
0.080
MutPred
0.39
Gain of methylation at K222 (P = 0.0935);
MVP
0.52
MPC
0.39
ClinPred
0.066
T
GERP RS
0.12
Varity_R
0.073
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs376654190; hg19: chrX-77224487; COSMIC: COSV58451676; COSMIC: COSV58451676; API